300 related articles for article (PubMed ID: 31838085)
1. Androgen-induced expression of DRP1 regulates mitochondrial metabolic reprogramming in prostate cancer.
Lee YG; Nam Y; Shin KJ; Yoon S; Park WS; Joung JY; Seo JK; Jang J; Lee S; Nam D; Caino MC; Suh PG; Chan Chae Y
Cancer Lett; 2020 Feb; 471():72-87. PubMed ID: 31838085
[TBL] [Abstract][Full Text] [Related]
2. Novel role of androgens in mitochondrial fission and apoptosis.
Choudhary V; Kaddour-Djebbar I; Lakshmikanthan V; Ghazaly T; Thangjam GS; Sreekumar A; Lewis RW; Mills IG; Bollag WB; Kumar MV
Mol Cancer Res; 2011 Aug; 9(8):1067-77. PubMed ID: 21724752
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer.
Bader DA; Hartig SM; Putluri V; Foley C; Hamilton MP; Smith EA; Saha PK; Panigrahi A; Walker C; Zong L; Martini-Stoica H; Chen R; Rajapakshe K; Coarfa C; Sreekumar A; Mitsiades N; Bankson JA; Ittmann MM; O'Malley BW; Putluri N; McGuire SE
Nat Metab; 2019 Jan; 1(1):70-85. PubMed ID: 31198906
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of androgen receptor expression induces cell death in prostate cancer cells.
Song IS; Jeong YJ; Kim J; Seo KH; Baek NI; Kim Y; Kim CS; Jang SW
Cell Mol Life Sci; 2020 Nov; 77(22):4663-4673. PubMed ID: 31894360
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
Shafi AA; Yen AE; Weigel NL
Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
[TBL] [Abstract][Full Text] [Related]
6. Focally amplified lncRNA on chromosome 1 regulates apoptosis of esophageal cancer cells via DRP1 and mitochondrial dynamics.
Liu T; Wang Z; Zhou R; Liang W
IUBMB Life; 2019 Feb; 71(2):254-260. PubMed ID: 30501006
[TBL] [Abstract][Full Text] [Related]
7. MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer.
Crowell PD; Giafaglione JM; Jones AE; Nunley NM; Hashimoto T; Delcourt AML; Petcherski A; Agrawal R; Bernard MJ; Diaz JA; Heering KY; Huang RR; Low JY; Matulionis N; Navone NM; Ye H; Zoubeidi A; Christofk HR; Rettig MB; Reiter RE; Haffner MC; Boutros PC; Shirihai OS; Divakaruni AS; Goldstein AS
Cell Rep; 2023 Oct; 42(10):113221. PubMed ID: 37815914
[TBL] [Abstract][Full Text] [Related]
8. SREBF1 Activity Is Regulated by an AR/mTOR Nuclear Axis in Prostate Cancer.
Audet-Walsh É; Vernier M; Yee T; Laflamme C; Li S; Chen Y; Giguère V
Mol Cancer Res; 2018 Sep; 16(9):1396-1405. PubMed ID: 29784665
[TBL] [Abstract][Full Text] [Related]
9. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer.
Gao T; Zhang X; Zhao J; Zhou F; Wang Y; Zhao Z; Xing J; Chen B; Li J; Liu S
Cancer Lett; 2020 Jan; 469():89-101. PubMed ID: 31639424
[TBL] [Abstract][Full Text] [Related]
10. Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer.
Audet-Walsh É; Dufour CR; Yee T; Zouanat FZ; Yan M; Kalloghlian G; Vernier M; Caron M; Bourque G; Scarlata E; Hamel L; Brimo F; Aprikian AG; Lapointe J; Chevalier S; Giguère V
Genes Dev; 2017 Jun; 31(12):1228-1242. PubMed ID: 28724614
[TBL] [Abstract][Full Text] [Related]
11. SIRT2 regulates mitochondrial dynamics and reprogramming via MEK1-ERK-DRP1 and AKT1-DRP1 axes.
Cha Y; Kim T; Jeon J; Jang Y; Kim PB; Lopes C; Leblanc P; Cohen BM; Kim KS
Cell Rep; 2021 Dec; 37(13):110155. PubMed ID: 34965411
[TBL] [Abstract][Full Text] [Related]
12. MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer.
Adler D; Menon R; Braun M; Offermann A; Queisser A; Boehm D; Vogel W; Rüenauver K; Ruiz C; Zellweger T; Svensson M; Andren O; Kristiansen G; Wernert N; Bubendorf L; Kirfel J; Biskup S; Perner S
Int J Cancer; 2014 Jul; 135(1):19-26. PubMed ID: 24374838
[TBL] [Abstract][Full Text] [Related]
13. GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress.
Gonzalez-Menendez P; Hevia D; Alonso-Arias R; Alvarez-Artime A; Rodriguez-Garcia A; Kinet S; Gonzalez-Pola I; Taylor N; Mayo JC; Sainz RM
Redox Biol; 2018 Jul; 17():112-127. PubMed ID: 29684818
[TBL] [Abstract][Full Text] [Related]
14. The activation of OR51E1 causes growth suppression of human prostate cancer cells.
Maßberg D; Jovancevic N; Offermann A; Simon A; Baniahmad A; Perner S; Pungsrinont T; Luko K; Philippou S; Ubrig B; Heiland M; Weber L; Altmüller J; Becker C; Gisselmann G; Gelis L; Hatt H
Oncotarget; 2016 Jul; 7(30):48231-48249. PubMed ID: 27374083
[TBL] [Abstract][Full Text] [Related]
15. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer.
Han W; Gao S; Barrett D; Ahmed M; Han D; Macoska JA; He HH; Cai C
Oncogene; 2018 Feb; 37(6):710-721. PubMed ID: 29059155
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk Between Androgen-sensitive and Androgen-insensitive Prostate Cancer Cells.
Takezawa Y; Izumi K; Machioka K; Iwamoto H; Naito R; Makino T; Kadomoto S; Natsagdorj A; Kadono Y; Keller ET; Zhang J; Mizokami A
Anticancer Res; 2018 Apr; 38(4):2045-2055. PubMed ID: 29599322
[TBL] [Abstract][Full Text] [Related]
18. Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism.
Shah S; Carriveau WJ; Li J; Campbell SL; Kopinski PK; Lim HW; Daurio N; Trefely S; Won KJ; Wallace DC; Koumenis C; Mancuso A; Wellen KE
Oncotarget; 2016 Jul; 7(28):43713-43730. PubMed ID: 27248322
[TBL] [Abstract][Full Text] [Related]
19. [Regulatory effect of Skp2 on the expression and transactivation of the androgen receptor in the progression of castration-resistant prostate cancer].
Song YT; Wu KJ; Wang XY; Na YG; Yin CM
Zhonghua Nan Ke Xue; 2016 Feb; 22(2):122-7. PubMed ID: 26939395
[TBL] [Abstract][Full Text] [Related]
20. RhoA regulates Drp1 mediated mitochondrial fission through ROCK to protect cardiomyocytes.
Brand CS; Tan VP; Brown JH; Miyamoto S
Cell Signal; 2018 Oct; 50():48-57. PubMed ID: 29953931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
